Skip to main content
. Author manuscript; available in PMC: 2012 Sep 10.
Published in final edited form as: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD005431. doi: 10.1002/14651858.CD005431.pub2
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate
5.1 Short-term visual acuity from 20/20 to 20/40 3 303 Odds Ratio(M-H, Fixed, 95% CI) 1.65[0.91, 2.99]
5.2 Time to resolution of primary hemorrhage (days) 5 Other data No numeric data
5.3 Risk of secondary hemorrhage 5 578 Odds Ratio(M-H, Fixed, 95% CI) 0.25[0.13, 0.49]
5.4 Time to rebleed (days) 5 Other data No numeric data
5.5 Risk of corneal bloodstain 2 Odds Ratio(M-H, Fixed, 95% CI) No totals
5.6 Risk of glaucoma or elevated IOP 4 543 Odds Ratio(M-H, Fixed, 95% CI) 1.23[0.70, 2.16]
5.7 Risk of optic atrophy 1 Odds Ratio(M-H, Fixed, 95% CI) No totals
5.8 Adverse effects: Nausea or vomiting 2 Odds Ratio(M-H, Fixed, 95% CI) No totals
5.9 Duration of hospitalization (days) 3 Other data No numeric data